1. Home
  2. DNLI vs SHOO Comparison

DNLI vs SHOO Comparison

Compare DNLI & SHOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Denali Therapeutics Inc.

DNLI

Denali Therapeutics Inc.

HOLD

Current Price

$23.27

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Logo Steven Madden Ltd.

SHOO

Steven Madden Ltd.

HOLD

Current Price

$41.44

Market Cap

3.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
DNLI
SHOO
Founded
2013
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Shoe Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.2B
IPO Year
2017
1996

Fundamental Metrics

Financial Performance
Metric
DNLI
SHOO
Price
$23.27
$41.44
Analyst Decision
Strong Buy
Buy
Analyst Count
14
7
Target Price
$34.33
$42.14
AVG Volume (30 Days)
1.2M
844.1K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
2.27%
EPS Growth
N/A
N/A
EPS
N/A
1.38
Revenue
N/A
$2,534,109,000.00
Revenue This Year
N/A
$12.39
Revenue Next Year
$408.85
$5.90
P/E Ratio
N/A
$31.29
Revenue Growth
N/A
11.00
52 Week Low
$12.58
$28.91
52 Week High
$27.30
$49.70

Technical Indicators

Market Signals
Indicator
DNLI
SHOO
Relative Strength Index (RSI) 41.67 32.03
Support Level $22.32 $41.99
Resistance Level $23.62 $44.62
Average True Range (ATR) 0.76 0.98
MACD -0.18 -0.66
Stochastic Oscillator 8.33 5.79

Price Performance

Historical Comparison
DNLI
SHOO

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.

About SHOO Steven Madden Ltd.

Steven Madden Ltd and its subsidiaries design, source, and market branded and private label footwear, accessories, and apparel. Its offerings include contemporary styles and core products, known for design creativity, trend-right offerings, high quality, and accessible price points. It operates through four segments: Wholesale Footwear, which generates maximum revenue and sells footwear globally; Wholesale Accessories/Apparel, which sells handbags and apparel through wholesale channels; Direct-to-Consumer, which sells footwear, handbags, apparel, and accessories through stores, outlets, e-commerce, and concessions; and Licensing, which licenses Steve Madden, Betsey Johnson, and Kurt Geiger trademarks, with the Company generating the majority of its revenue from the USA.

Share on Social Networks: